Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease
Author(s) -
Sidonie Lambert-Niclot,
Philippe Flandre,
Isabelle Malet,
Ana Canestri,
Cathia Soulié,
Roland Tubiana,
C. Brunet,
Marc Wirden,
Christine Katlama,
Vincent Cálvez,
AnneGeneviève Marcelin
Publication year - 2008
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkn338
Subject(s) - darunavir , virology , human immunodeficiency virus (hiv) , mutation , protease , genetics , selection (genetic algorithm) , drug resistance , biology , lentivirus , medicine , microbiology and biotechnology , antiretroviral therapy , viral disease , viral load , gene , enzyme , computer science , biochemistry , artificial intelligence
To search for genetic factors in the protease and gag regions (NC-p1/TFP-p6/p6pol) involved in selection of darunavir resistance mutations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom